Mesa Laboratories supplies life-sciences quality-control tools and regulated testing products. Its portfolio includes sterilization and disinfection monitoring, calibration and measurement instruments, and bioprocessing-related products. Pharmaceutical manufacturers, hospitals, and laboratories use its technologies to validate critical processes and demonstrate compliance with quality requirements.
Mesa Laboratories, Inc. (MLAB) has a MarketKingdoms composite score of 70.0 (B), an B-range rating. It ranks 326th of 1,866 covered companies, 57th of 176 in Technology (sector average 67.1) and 3rd of 18 in Scientific & Technical Instruments. Scores as of 2026-10-26.
Its strongest lenses are Industry opportunity at 88 (Technology average 88) and Stock selection at 81 (Technology average 82). Its weakest lenses are Expansion (growth) at 25 (sector average 51) and Quality (profitability) at 52 (sector average 50).
| Lens | Type | MLAB | Technology average | Scientific & Technical Instruments average | Percentile in sector |
|---|---|---|---|---|---|
| Industry opportunity | Research signal | 88 | 88 | 88 | 42nd |
| Stock selection | Research signal | 81 | 82 | 81 | 35th |
| KPI momentum | Research signal | 75 | 84 | 83 | 18th |
| Catalyst watch | Research signal | 73 | 76 | 73 | 25th |
| Price (valuation) | Fundamental lens | 71 | 50 | 50 | 82nd |
| Expansion (growth) | Fundamental lens | 25 | 51 | 38 | 16th |
| Quality (profitability) | Fundamental lens | 52 | 50 | 44 | 56th |
| Trend (momentum) | Fundamental lens | 77 | 50 | 43 | 93rd |
The most recent call analysed was held on 2026-08-10 (fiscal 2027 Q1). After it the composite moved from 81.8 to 83.4. MarketKingdoms checks what management promised on each call against what it later delivered.
The composite at the time of each event; today's composite is 70.0.
The stock's valuation gap is -6.9%: its price is below the path its market, sector and industry moves explain (undervalued versus the model path). Factor sensitivity: market beta 1.48, sector beta -0.12, industry beta -0.16; the factor model explains 8% of its moves (R²).
| Company | Composite | Grade | Valuation gap |
|---|---|---|---|
| Keysight Technologies, Inc. (KEYS) | 74.0 | B+ | -5.7% |
| Garmin Ltd. (GRMN) | 70.1 | B+ | -2.1% |
| Cognex Corporation (CGNX) | 69.3 | B | +1.6% |
| MKS Instruments, Inc. (MKSI) | 67.2 | B | -37.4% |
| Itron, Inc. (ITRI) | 66.8 | B | -7.4% |
| Teledyne Technologies Incorporated (TDY) | 66.5 | B | -7.2% |
| Trimble Inc. (TRMB) | 65.8 | B | -1.6% |
| Novanta Inc. (NOVT) | 65.0 | B | +12.8% |
Mesa Laboratories, Inc. financial statements · Technology sector ranking · Scientific & Technical Instruments industry ranking · All covered companies
The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.
General information, not investment advice.